Monarch Medical Technologies
Charles Cornish has an extensive background in healthcare technology, serving as the Chief Executive Officer at Monarch Medical Technologies. Prior to this, Charles held leadership roles at companies such as Tabula Rasa HealthCare and DoseMe. With experience in investment management at Dalton Nicol Reid and a corporate finance background at KPMG, Charles brings a well-rounded skill set to their leadership positions. Their education includes a degree from the Massachusetts Institute of Technology in Healthcare AI and an MBA from Melbourne Business School.
Monarch Medical Technologies
Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities of treating patients with diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, impaired kidney function, residual insulin, and presence of steroids.